Stephen Jensik to Kidney Failure, Chronic
This is a "connection" page, showing publications Stephen Jensik has written about Kidney Failure, Chronic.
Connection Strength
0.254
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
Score: 0.148
-
Outcomes after combined liver-kidney transplant vs. kidney transplant followed by liver transplant. Clin Transplant. 2015 Jan; 29(1):60-6.
Score: 0.106